🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Fetal Health Locus of Control, Maternal Anxiety, and Cardiotocography in High-Risk Pregnancies

Recruitingn/aAges 18 Years - 45 YearsFemaleIstanbul Training and Research Hospital
NCT07774936 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational cross-sectional study aims to evaluate the relationships among fetal health locus of control (FHLC) perceptions, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnant women. Pregnant women at 32 weeks of gestation or later who undergo routine non-stress testing (NST) at the Perinatology Outpatient Clinic will be invited to participate. On the same day as the routine NST, participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory. Associations between FHLC dimensions, maternal anxiety levels, and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Singleton pregnancy at 32 weeks of gestation or later * Being followed for a high-risk pregnancy * No known diagnosed psychiatric disorder and no current psychiatric medication use * Absence of a fetal condition considered likely to affect the NST tracing * Maternal age between 18 and 45 years Exclusion Criteria: * Gestational age below 32 weeks and/or multiple pregnancy * Presence of a fetal condition considered likely to affect the NST tracing * Acute maternal infection or an obstetric emergency * Known diagnosed psychiatric disorder and/or current psychiatric medication use * Maternal age below 18 years or above 45 years
💊

What it tests

  • Not listed
📍

Where

1 site
Istanbul Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy